Scientific Advisory Board
The Scientific Advisory Board is composed of nationally and internationally recognized scientists and clinicians. This board advises St. Jude leadership on the quality, direction and future opportunities of the institution’s research and clinical programs, helping ensure our work remains at the forefront of pediatric medicine and discovery.
John Maris, MD – Chair
Giulio D’Angio Professor of Pediatric Oncology
Perelman School of Medicine at the University of Pennsylvania
Division of Oncology
Children’s Hospital of Philadelphia
Philadelphia, PA
Smita Bhatia, MD, MPH – Vice Chair
Gay and Bew White Endowed Chair in Pediatric Oncology
Professor, Pediatric Oncology
Vice Chair for Outcomes Research, Department of Pediatrics
Director, Institute for Cancer Outcomes and Survivorship
University of Alabama at Birmingham School of Medicine
Birmingham, AL
Kevin Shannon, MD – Vice Chair
American Cancer Society Research Professor
Roma and Marvin Auerback Distinguished Professorship in Pediatric Molecular Oncology
University of California – San Francisco
Helen Diller Family Comprehensive Cancer Center
San Francisco, CA
Susan Ackerman, PhD
HHMI Investigator
Stephen W. Kuffler Chair in Biology
Distinguished Professor, Department of Neurobiology
Vice Dean for Research, UCSD School of Medicine
University of California – San Diego
La Jolla, CA
Scott Armstrong, MD, PhD
President, Dana-Farber / Boston Children’s Cancer and Blood Disorders Center Chair, Department of Pediatric Oncology
Associate Chief, Division of Hematology/Oncology
Boston Children’s Hospital
David G. Nathan Professor of Pediatrics
Harvard Medical School
Chief Research Strategy Officer
Senior Vice President for Drug Discovery
Dana-Farber Cancer Institute
Boston, MA
Carsten Bönnemann, MD
Senior Investigator and Chief, Neuromuscular & Neurogenetic Disorders of Childhood Section
National Institutes of Health
Neuromuscular & Neurogenetic Diseases of Childhood, Neurogenetics Branch
Bethesda, MD
Michael Eck, MD, PhD
Professor of Biological Chemistry and Molecular Pharmacology, Harvard Medical School
Professor of Cancer Biology, Dana-Farber Cancer Institute
Dana-Farber / Harvard Cancer Center
Boston, MA
David Ginsburg, MD
James V. Neel Distinguished University Professor
Departments of Internal Medicine, Human Genetics, and Pediatrics
University of Michigan Medical School
Ann Arbor, MI
Nathanael Gray, PhD
Member, ChEM-H
Program Leader, Small Molecule Drug Discovery for the Innovative Medicines Accelerator
Co-Director, Cancer Drug Discovery
Co-Leader, Cancer Therapeutics Research Program
Krishnan-Shah Family Professor, Chemical and Systems Biology
Stanford University
Stanford, CA
Katherine High, MD
Emeritus Professor of Pediatrics, University of Pennsylvania Perelman School of Medicine
Visiting Professor, The Rockefeller University
The Rockefeller University
New York, NY
Patrick Loehrer, MD
HH Gregg Professor of Oncology
Distinguished Professor
Indiana University School of Medicine
Indianapolis, IA
Sallie Permar, MD, PhD
Pediatrician-in-Chief
New York-Presbyterian/Weill Cornell Medical Center
Nancy C. Paduano Professor and Chair
Professor of Immunology and Microbial Pathogenesis
Weill Cornell Medicine
Department of Pediatrics
New York, NY
Rob Pieters, MD, PhD, MSc
Board of Directors, Chief Medical Officer
Princess Maxima Center for Pediatric Oncology
Utrecht, Netherlands
Stanley R. Riddell, MD
Burke O’Reilly Family Endowed Chair in Immunotherapy
Professor, Department of Medicine
Fred Hutchinson Cancer Research Center
Seattle, WA
Kimberly Stegmaier, MD
Ted Williams Investigator
Dana-Farber Cancer Institute
Vice Chair of Pediatric Oncology Research
Dana-Farber Institute
Co-Director, Pediatric Hematologic Malignancy Program
Boston Children’s Hospital and Dana-Farber Cancer Institute
Professor of Pediatrics
Harvard Medical School
Member, Broad Institute
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Boston, MA
Viviane Tabar, MD
Theresa C. Feng Professor in Neurosurgical Oncology
Chair, Department of Neurosurgery
Memorial Sloan Kettering Cancer Center
New York, NY
Sarah Teichmann, FMedSci FRS
Professor
Wellcome – MRC Cambridge Stem Cell Institute
University of Cambridge Department of Medicine
United Kingdom
Cancer Center Advisory Board
The Cancer Center Advisory Board provides guidance specific to the St. Jude Comprehensive Cancer Center. This board focuses on Cancer Center strategy, performance and alignment with national cancer research priorities, including those outlined by the National Cancer Institute.
Scott A. Armstrong, MD, PhD
Chairman, Department of Pediatric Oncology
Dana-Farber Cancer Institute
Edward (Ed) Chu, MD
Director, Albert Einstein Cancer Center
Vice-President of Cancer Medicine, Montefiore Medicine
Roger and Carol Einiger Professor of Cancer Medicine
Professor of Medicine and Pharmacology
Albert Einstein College of Medicine
Eric Fearon, MD, PhD
Professor, Departments of Internal Medicine, Human Genetics, and Pathology
Director, University of Michigan Rogel Cancer Center
Emanuel N. Maisel Professor of Oncology
Beverly Ginsburg-Cooper
Senior Director & Cancer Center Service Team Lead
Huron Consulting Group
Stephen Hunger, MD
Professor of Pediatrics
Associate Dir. (Pediatric Research), Abramson Cancer Ctr.
University of Pennsylvania Perelman School of Medicine
Chief, Division of Pediatric Oncology
Director, Center for Childhood Cancer Research
Jeffrey E. Perelman Distinguished Chair in the Dep of Pediatrics
Children’s Hospital of Philadelphia
Arnold Kriegstein, MD, PhD
Director, Developmental and Stem Cell Biology Program
UCSF School of Medicine
Michelle LeBeau, PhD
Chief Scientific Officer
Cancer Prevention and Research Institute of Texas
Scott W. Lowe, PhD
Investigator, Howard Hughes Medical Institute
Chair, Cancer Biology & Genetics Program
Chair, Geoffrey Beene Cancer Research Center
Memorial Sloan Kettering Cancer Center
Stephen D. Nimer, MD
Director, Sylvester Comprehensive Cancer Center
Oscar de la Renta Endowed Chair in Cancer Research
Professor of Medicine, Biochemistry & Molecular Biology
University of Miami Health System
Stanley Riddell, MD
Prof., Fred Hutchinson Cancer Research Ctr
Department of Medicine, University of Washington
Kevin M. Shannon, MD
Professor, Department of Pediatrics, UCSF
Paul M. Sondel, MD, PhD
Walker Professor of Pediatrics, Human Oncology, Director of Research
UW Carbone Cancer Center and American Family Children’s Hospital
University of Wisconsin
Cornelia M. Ulrich, MS, PhD (Neli)
Executive Director, Comprehensive Cancer Center at Huntsman Cancer Institute
Jon M. and Karen Huntsman Presidential Professor in Cancer Research
Professor, Department of Population Health Sciences, University of Utah
Brenda Weigel, MD, MSc
Division Director, Pediatric Hematology/Oncology
University of Minnesota
Associate Director, Cancer Experimental Therapeutics Initiative & Co-Director Sarcoma Program
Masonic Cancer Center
Pediatric Hematology/Oncology
More to discover
-
St. Jude Leadership
The St. Jude senior management team is focused on making the best decisions for the good of hospital patients and employees.
-
ALSAC/St. Jude Boards of Directors and Governors
The ALSAC/St. Jude Boards of Directors and Governors serve without compensation and provide governance and strategic oversight for both ALSAC and St. Jude.
-
Our purpose
St. Jude exists to solve problems that others often cannot or will not solve – pursuing cures and prevention for the most serious diseases children face, and ensuring that discoveries reach children everywhere, not only those treated in Memphis.
